Join AlphaMaven

The Home Of Alternative Investments

Register For Free Learn More Create Investment Listing

Most Visited Alternative Investment Industry Website. Over 50,000 visitors per month

Alternative Investment Posts

Lionschain Capital - Why Invest In Crypto?
Crypto Lionschain Capital Views: 566

Lionschain Capital - Why Invest In Crypto?

Created in 2009 by the pseudonymous Satoshi Nakamoto, Bitcoin is an open source, non-state-backed finance network. The launch of Bitcoin debuted the use of blockchain technology. Blockchain technology enabled the creation of digital scarcity. The native currency of the Bitcoin network is the crypto commodity BTC. The Bitcoin network is operated by a public mesh of node operators, which process transactions and monitor the state of the limi


Member Posts:

Most popular| Most recent
AlphaMaven Crypto Traders Index
Crypto AlphaMaven Crypto Traders Index #Investment Update
AlphaMaven Cannabis Index
Cannabis AlphaMaven Cannabis Index #Investment Update
Lyons Covered Call AI March 2025
Hedge Fund Lyons Covered Call AI #Presentation
Lyons Tactical Allocation Portfolio - Company Performance Update Q4 2024
Hedge Fund Lyons Tactical Allocation Portfolio #Presentation
Lyons Innovation And Growth December 2024 -  Fact Sheet
Hedge Fund Lyons Innovation and Growth Portfolio #Presentation
Alpha Alternative Assets Fund - Fact Sheet
Hedge Fund Alpha Alternative Assets Fund
ParaImbal, LP Investor Presentation - March 2025
Managed Futures Paraimbal #Presentation
Meteora Select Trading Opportunities, LP - AlphaMaven Performance Report
Hedge Fund Meteora Select Trading Opportunities, LP #Investment Update
ParaImbal, LP - AlphaMaven Performance Report
Managed Futures Paraimbal #Investment Update
Rome Capital Long Levered Strategy - AlphaMaven Performance Report
Hedge Fund Rome Capital Long Levered Strategy #Investment Update
Andrea Alms Video:  Money In Motion 153 - FDA Staff Cuts - Biotech Regulatory Delays M ...
Private Equity BrookDell Partners #Video
Andrea Alms Video:  Money In Motion 152 - Tariffs Pharma/Biotech Market Update
Private Equity BrookDell Partners #Video
Andrea Alms Video:  Money In Motion 151 - Ozempic Impact & GLP-1 Receptor Agonist Mark ...
Private Equity BrookDell Partners #Video
Andrea Alms Video:  Money In Motion 150 - Gene Therapy Adeno-Associated Virus (AAV)
Private Equity BrookDell Partners #Video
Andrea Alms Video:  Money In Motion 149 - Pediatric Rare Disease Market
Private Equity BrookDell Partners #Video
Robosig FX Alpha Gen Fund Posts Its March 2025 Results
Hedge Fund RoboSig FX Alpha Gen Fund #Investment Update
ARB Flagship Fund - AlphaMaven Performance Report
Hedge Fund ARB Flagship Fund #Investment Update
SBGM Futures Portfolio Strategy Performance Report
Managed Futures SBGM Futures Portfolio Strategy #Investment Update
AlphaMaven Managed Futures Index
Managed Futures AlphaMaven Managed Futures Index #Investment Update
AlphaMaven Real Estate Index
Real Estate AlphaMaven Real Estate Index #Investment Update
CREATE A FREE MEMBERSHIP
View Member Posts Listings
SPONSORED BY
Be Seen - Advertise With Us
Click to Discuss
FEATURED MEMBER POSTS
Andrea Alms Video:  Money In Motion 153 - FDA Staff Cuts - Biotech Regulatory Delays Market Update
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 147 - Pediatric Healthcare Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 149 - Pediatric Rare Disease Market
- posted by: BrookDell Partners
Andrea Alms Video: Money In Motion 148 - Water Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 151 - Ozempic Impact & GLP-1 Receptor Agonist Market Update
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 152 - Tariffs Pharma/Biotech Market Update
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 150 - Gene Therapy Adeno-Associated Virus (AAV)
- posted by: BrookDell Partners
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates

Subscribe to our FREE DAILY newsletter

Please Select Industry Primary Role*
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.